Evaluation of IP-10 in IGRA for LTBI diagnosis

L. Petrone (Rome, Italy), E. Petruccioli (Rome, Italy), V. Vanini (Rome, Italy), T. Chiacchio (Rome, Italy), G. Cuzzi (Rome, Italy), F. Palmieri (Rome, Italy), G. Ippolito (Rome, Italy), D. Goletti (Rome, Italy)

Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Session: Tuberculosis transmission and screening strategies
Session type: Poster Discussion
Number: 5271
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Petrone (Rome, Italy), E. Petruccioli (Rome, Italy), V. Vanini (Rome, Italy), T. Chiacchio (Rome, Italy), G. Cuzzi (Rome, Italy), F. Palmieri (Rome, Italy), G. Ippolito (Rome, Italy), D. Goletti (Rome, Italy). Evaluation of IP-10 in IGRA for LTBI diagnosis. 5271

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical evaluation of IP-10 and MIG including IGRAs (QFT and T-SPOT) for the diagnosis of tuberculosis infection
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014

Clinical management of LTBI (PDF)// IGRAs for the diagnosis of tuberculosis (PPT)
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012


Comparative study of the usefulness of TST and three interferon-gamma release assasys (IGRAs) for the differential diagnosis of pulmonary tuberculosis
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011

A three way comparison of IP-10, QFT-IT and TSPOT.TB for the diagnosis of infection with M.tuberculosis
Source: Annual Congress 2010 - Scientific advances in tuberculosis
Year: 2010

Clinical evaluation of interferon-gamma release assay (IGRA) in patients with nontuberculous mycobacterial disease
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012

Concordance between tuberculin skin testing and interferon-gamma release assays in diagnosis of latent tuberculosis infection among HIV-infected individuals
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012

Clinical evaluation of diagnostic potential of several biomarkers for immunodiagnosis of tuberculosis infection including IGRAs
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015

Value of QFT-IT test for diagnosing latent TB infection in HIV+
Source: ISSN=ISSN 1810-6838, ISBN=, page=284
Year: 2007

Differentiating smear-negative active tuberculosis from LTBI by BAL ELISPOT: a TBNET study
Source: Annual Congress 2009 - Frontiers in the diagnosis of tuberculosis
Year: 2009



Quantiferon-TB Gold in tube assay for detecting latent TB infection in immigrants and TB contacts
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013

Interferon-gamma release assays (IGRA) for latent tuberculosis infection (LTBI) in children
Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood
Year: 2011


Performance of two interferon-gamma release assays (T-SPOT.TB and QuantiFERON-TB GOLD In Tube) increase diagnostic yield of tuberculin skin testing for detection of latent tuberculosis in patients with inflammatory bowel disease
Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Year: 2011


Discordance between tuberculin skin tests (TST) and interferon gamma release assays (IGRAs): Are we over-treating LTBI?
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018




Comparison of BAL ELISPOT and NAT for the diagnosis of smear-negative tuberculosis – a TBNET study
Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease
Year: 2008


Predictive value of a whole-blood IGRA for the development of active TB disease
Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease
Year: 2008


The effect of smoking on QuantiFERON results in diagnosis of latent tuberculosis infection
Source: International Congress 2016 – Latent tuberculosis infection
Year: 2016


QFT-GIT vs TST in diagnosis of latent tuberculosis infection (LTBI) in Poland
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011


A comparison of the accuracy of IP-10 and IFN-γ for the diagnosis of TB
Source: Annual Congress 2009 - Frontiers in the diagnosis of tuberculosis
Year: 2009


QuantiFERON-TB Gold in-tube test for diagnosis of latent tuberculosis (TB) infection among immunocompromised adults
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013



Evaluation of cut-off values of QuantiFERON-TB Gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012